Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 8.56B | 7.36B | 5.52B | 5.20B | 4.88B |
Gross Profit | 3.21B | 2.72B | 2.08B | 1.98B | 1.83B |
EBITDA | 1.63B | 1.15B | 755.00M | 853.00M | 736.00M |
Net Income | 890.00M | 609.00M | 355.00M | 427.00M | 254.00M |
Balance Sheet | |||||
Total Assets | 16.50B | 16.11B | 7.95B | 8.28B | 8.75B |
Cash, Cash Equivalents and Short-Term Investments | 1.12B | 1.02B | 944.00M | 1.35B | 1.88B |
Total Debt | 2.02B | 2.39B | 1.95B | 2.44B | 3.08B |
Total Liabilities | 5.62B | 5.94B | 4.45B | 5.05B | 5.77B |
Stockholders Equity | 10.64B | 10.17B | 3.49B | 3.22B | 2.97B |
Cash Flow | |||||
Free Cash Flow | 942.00M | 566.00M | 388.00M | 330.00M | 641.00M |
Operating Cash Flow | 1.26B | 837.00M | 596.00M | 538.00M | 824.00M |
Investing Cash Flow | -482.00M | -628.00M | -191.00M | -183.00M | -169.00M |
Financing Cash Flow | -615.00M | -157.00M | -790.00M | -855.00M | 473.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $8.43B | 28.93 | 17.61% | 0.84% | 3.89% | 8.17% | |
78 Outperform | $17.24B | 27.02 | 18.59% | 0.95% | -0.42% | 3.23% | |
74 Outperform | $3.95B | 27.53 | 17.68% | 1.06% | 10.96% | 43.44% | |
74 Outperform | $6.89B | 24.69 | 14.00% | 1.59% | 4.23% | 20.40% | |
74 Outperform | $555.52M | 46.33 | 10.86% | ― | 13.13% | 164.29% | |
72 Outperform | $31.56B | 34.88 | 8.62% | 1.23% | 8.14% | 32.64% | |
65 Neutral | $10.81B | 15.25 | 5.26% | 1.93% | 3.11% | -26.99% |
On May 13, 2025, Xylem Inc. held its Annual Meeting of Shareholders, where 88.68% of the company’s outstanding common stock was represented. Key outcomes included the election of nine directors, ratification of Deloitte & Touche LLP as the independent auditor for 2025, approval of executive compensation, and the rejection of a shareholder proposal for special shareholder meeting improvements.
The most recent analyst rating on (XYL) stock is a Buy with a $148.00 price target. To see the full list of analyst forecasts on Xylem stock, see the XYL Stock Forecast page.